TickerFactsScreenerDevelopers

Protalix BioTherapeutics, Inc. (PLX) — Revenue

Annual figures by fiscal year, from SEC filings.

2009: $388.0K2010: $6.64M2011: $8.39M2012: $34.87M2013: $02014: $3.52M2015: $4.36M2016: $9.20M2017: $21.08M2018: $34.24M2019: $54.69M2020: $62.90M2021: $38.35M2022: $47.64M2023: $65.49M2024: $53.40M2025: $52.74M$52.74M
2009Revenue (USD)2025
Fiscal YearRevenueChange YoY
2025$52.74M-1.2%
2024$53.40M-18.5%
2023$65.49M+37.5%
2022$47.64M+24.2%
2021$38.35M-39.0%
2020$62.90M+15.0%
2019$54.69M+59.7%
2018$34.24M+62.4%
2017$21.08M+129.1%
2016$9.20M+110.8%
2015$4.36M+23.9%
2014$3.52M—
2013$0-100.0%
2012$34.87M+315.8%
2011$8.39M+26.3%
2010$6.64M+1611.9%
2009$388.0K—